Dihydrozeatin-7-N-dihydrozeatin

Metabolite details

Identifier

WSELIHNWDGFXRQ-UFZVAZPKSA-N

InChI Key

WSELIHNWDGFXRQ-UFZVAZPKSA-N

IUPAC name

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[6-[(4-hydroxy-3-methylbutyl)amino]purin-7-yl]oxane-3,4,5-triol

Preferred name

Dihydrozeatin-7-N-dihydrozeatin

INN name

—

Synonym

—

ChEBI

CHEBI:172616

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• RU-_Control_vs_RU+_Switch
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d